Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease ; volume:13 ; number:1 ; day:29 ; month:4 ; year:2023 ; pages:1-7 ; date:12.2023
Scientific reports ; 13, Heft 1 (29.4.2023), 1-7, 12.2023
- Creator
-
Martin-Arranz, M. D.
García-Ramírez, L.
Hernandez-Perez, M.
Montero Vega, D.
Martín-Arranz, E.
Sánchez-Azofra, M.
Poza Cordon, J.
Rueda Garcia, J. L.
Noci Belda, J.
Verges Martínez-Meco, T.
Blanco San Miguel, P.
Suarez Ferrer, C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-33402-w
- URN
-
urn:nbn:de:101:1-2023090510442079345424
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martin-Arranz, M. D.
- García-Ramírez, L.
- Hernandez-Perez, M.
- Montero Vega, D.
- Martín-Arranz, E.
- Sánchez-Azofra, M.
- Poza Cordon, J.
- Rueda Garcia, J. L.
- Noci Belda, J.
- Verges Martínez-Meco, T.
- Blanco San Miguel, P.
- Suarez Ferrer, C.
- SpringerLink (Online service)
Other Objects (12)
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!